¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sickle form"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • parasitic form
    ±â»ýÇü
  • ring-form
    ¹ÝÁöÇü, À±»óü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mycelial form
    ±Õ»çÇü
  • open chain form
    ¿­¸°»ç½½Çü
  • parasitic form
    ±â»ýÇü
  • pre-erythrocytic form
    ÀüÀûÇ÷±¸Çü
  • ring-form
    ¹ÝÁöÇü, À±»óü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sickle hemoglobin
    °â»óÇì¸ð±Û·Îºó.
  • sickle hemoglobin
    °â»óÇì¸ð±Û·Îºó(ÌÇßÒ¡­)
  • sickle syndrome
  • sickle thalassemia disease
    °â(Àû)Ç÷±¸Å»¶ó¼¼¹Ì¾Æº´.
  • sickle thalassemia disease
    °â(Àû)Ç÷±¸Å»¶ó¼¼¹Ì¾Æº´.
  • sickle thalassemia disease
    °â(Àû)Ç÷±¸Å»¶ó¼¼¹Ì¾Æº´(ÌÇ(îå)úìϹܻ
  • sickle-cell retinopathy
    °â»óÀûÇ÷±¸¸Á¸·º´Áõ
  • alveolar ridge running in concave form
    ¿ä¸¸ÇüÄ¡Á¶¿¬(èêØ¶úþöÍðËæÞ).
  • auxiliary retention form
    º¸Á¶Àû À¯ÁöÇüÅÂ(ÜÍð¾îÜë«ò¥û¡÷¾) õµ¿(ó¸÷Ó)ÀÇ .
  • balanced form
    ±ÕÇüÇü(гû¬û¡).
  • band form =stab cell
    °£»óÈ£Áß±¸
  • bell form
    Á¾Çü(̴̡).
  • bilinear form
    ½ÖÀÏÂ÷Çü½Ä(ËâËö̴̤ Ëà).
  • biphasic wave form
    ¾ç¸é ŽÃËÀÚ ÀÌ»ó¼º ÆÄÇü(廨ü÷®õºí­ì¶ßÈàõ÷îû¡).
  • box form
    »óÇü¿Íµ¿(ßÕû¡èÀ÷Ó)ÀÇ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • L-form
    LÇü(úþ)
  • replicating form
    º¹Á¦ Çü(úþ)
  • replicative form
    º¹Á¦ Çü(úþ)
  • Z form
    Z Çü(úþ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RSC rat spleen cell; rested state contraction; reversible sickle-cell; right subclavian
S/b sickle cell beta-thalassemia
SC conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia...
S-C sickle cell
SCA self-care agency; severe congenital anomaly; sickle-cell anemia; single-camera autostereoscopic [ima...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FDM Form-deprivation myopia
GST-P Glutathione S-transferase placental form
HGSHS:A Harvard Group Scale of Hypnotic Susceptibility, Form A
MOS SF-36 Medical Outcome Study Short Form 36
PAF Premenstrual Assessment Form
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chemical form
    È­ÇÐÀû Çü»ó
  • circumscribed form
    ±¹ÇѼº ÇüÅÂ
  • color form sorting test
    »öä ÇüÅ Ã߸®±â °Ë»ç
  • convenience form
    ÆíÀÇ ÇüÅÂ
    ÃæÀü¿¡ ÇÊ¿¬ÀûÀÎ ±âº»ÀûÀÎ ¿Íµ¿ÀÇ ÇüÅ·μ­ ¿Íµ¿Àº ¾ðÁ¦³ª ¸ðµç ÃæÀü Á¶ÀÛ¿¡ À־ ±× Á¶ÀÛÀ» ÆíÇÏ°Ô ÇÒ ¼ö ÀÖ´Â ÀûÀýÇÑ ÇüÅ·Π¿Íµ¿À» Çü¼ºÇÏ´Â °Í.
  • crescent form
    ¹Ý´ÞÇü, ¹Ý¿ùü, ¹Ý¿ùÇü
  • facial form
    ¾È¸ð
  • form-other
    Çü½Ä»óÀÇ ¸ñ
  • initial form
    Ãʱâ ÇüÅÂ
  • L-form
    L-Çü
  • large surface form
    ³ÐÀº ¸éÀÇ ÇüÅÂ
  • lethal form
    Ä¡»çÀûÀÎ ÇüÅÂ
  • liquid form
    ¾×ü »óÅÂ
    ¹°À̳ª ±â¸§°ú °°ÀÌ ÀÚÀ¯·ÎÀÌ À¯µ¿ÇÏ¿© ¿ë±âÀÇ ¸ð¾ç¿¡ µû¶ó ±× ¸ð¾çÀÌ º¯Çϸç ÀÏÁ¤ÇÑ ÇüŸ¦ °¡ÁöÁö ¾Ê°í ¾ÐÃàÇØµµ °ÅÀÇ ºÎÇǰ¡ º¯ÇÏÁö ¾Ê´Â ¹°Áú. Á¤È®È÷´Â ¾×ü »óŶó°í ÇÑ´Ù. ¼ö¸¹Àº ¹°Áú °¡¿îµ¥ »ó¿Â, »ó¾Ð¿¡¼­ ÀÌ¿Í °°Àº »óŸ¦ °¡Áö´Â °ÍÀº ºñ±³Àû ÀûÀ¸³ª, Àû´çÇÑ ¿Âµµ¿Í ¾Ð·ÂÀÇ Á¶°ÇÀÌ °®Ãß¾îÁö¸é °ÅÀÇ ¸ðµç ¹°ÁúÀÌ ¾×ü·Î º¯ÇÒ ¼ö ÀÖÀ¸¸ç, ¹Ý´ë·Î ¾×üµµ ´Ù½Ã ±âü³ª °íü·Î º¯ÇÒ ¼ö ÀÖ´Ù. Áï, ¾×ü¶ó´Â °ÍÀº ¹°Áú¿¡ °íÀ¯ÇÑ ¼ºÁúÀÌ ¾Æ´Ï¶ó Á¶°Ç¿¡ µû¶ó¼­ ±âü·Îµµ °íü·Îµµ º¯ÇÒ ¼ö ÀÖ´Â ¹°ÁúÀÇ Á¸Àç »óÅÂÀÇ Çϳª¿¡ ºÒ°úÇÏ´Ù. ÀÌ·± ¶æ¿¡¼­ °íü»ó, ±âü»ó¿¡ ´ëÇØ¼­ ¾×ü»óÀ̶ó°í ÇÏ´Â °æ¿ìµµ ÀÖ´Ù. ¶ÇÇÑ ÇϳªÀÇ ¹°ÁúÀÌ °íü¿¡¼­ ¾×ü·Î º¯È­ÇÏ´Â Çö»óÀ» À¶ÇØ, ¾×ü¸é¿¡¼­ ±âÈ­ÇÏ´Â °ÍÀ» Áõ¹ßÀ̶ó°í Çϳª, ±âÈ­´Â ¾×ü ³»ºÎ¿¡¼­µµ ÀϾ¸ç, ¾×ü°¡ Àü¸éÀûÀ¸·Î ±âü·Î º¯ÇÏ´Â Çö»óÀ» ºñµîÀ̶ó°í ÇÑ´Ù. ÀÏÁ¤ÇÑ ¾Ð·ÂÇÏ¿¡¼­ÀÇ
  • localized form
    ±¹¼Ò Çü
  • marginal form
    ¿Ü¿¬ ÇüÅÂ, º¯¿¬ ÇüÅÂ
  • mixed form
    È¥ÇÕ Çü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
sickle cell trait <haematology> This condition occurs in people who have one of two possible genes (i.e., they are heterozygous forthe allele) that code for the defective haemoglobin responsible for sickle cell anaemia.
The coditionis diagnosed by exposing an individual's red blood cells to a low oxygen environment, if the trait is present, the cells will turn to a sickle shape. People with this trait may suffer milder symptoms of sickle cell anaemia, or may have no symptoms. Some scientists believe the trait actually provides an evolutionary advantage in tropical environments because the slightly altered shape of the blood cells causes a person to be more resistant to malaria.
(09 Oct 1997)
sickle flap A sickle-shaped flap from the anterior scalp and one side of the forehead, based on the opposite temporal artery.
(05 Mar 2000)
sickle scotoma A comet-shaped scotoma, occurring in glaucoma, attached at the temporal end to the blind spot or separated from it by a narrow gap; the defect widens as it extends above and nasally curves around the fixation spot, and then extends downward to end exactly at the nasal horizontal meridian.
Synonym: Bjerrum's sign, sickle scotoma.
(05 Mar 2000)
a-form DNA <molecular biology> One of several forms that can be assumed by a double helix. A-DNA is stable in dehydrated conditions.
This form is less common than the dominant form found under physiological conditions -- beta-DNA. This form is also assumed by DNA-RNA hybrid helices and by regions of double-stranded RNA. It is a right-handed helix and is a more compact form than beta-DNA.
(09 Oct 1997)
boat form The less stable of two conformations assumed by 6-membered cyclic sugars (pyranoses) or cyclohexane derivatives, as opposed to chair form.
See: Haworth conformational formulas of cyclic sugars.
(05 Mar 2000)
cavity preparation form The configuration or shape of a cavity preparation.
(05 Mar 2000)
replicative form An intermediate stage in the replication of either DNA or RNA viral genomes that is usually double stranded, the altered, double-stranded form to which single-stranded coliphage DNA is converted after infection of a susceptible bacterium, formation of the complementary ("minus") strand being mediated by enzymes that were present in the bacterium before entrance of the viral ("plus") strand.
(05 Mar 2000)
resistance form The shape given to a cavity preparation that enables the dental restoration to withstand masticatory forces.
(05 Mar 2000)
retention form The shape of a cavity preparation that prevents displacement of the dental restoration by lateral or tipping forces as well as masticatory forces.
(05 Mar 2000)
chair form The more stable of two conformations assumed by 6-membered cyclic sugars (e.g., the pyranoses) or cyclohexane derivatives, as opposed to boat form.
See: Haworth conformational formulas of cyclic sugars.
(05 Mar 2000)
wave form The form of a pulse; e.g., an arterial pressure or displacement wave; or of the pacemaker pulse as demonstrated on the oscilloscope under a specified load.
Synonym: waveshape.
(05 Mar 2000)
wax form A pattern of wax that, when invested and burned out or otherwise eliminated, will produce a mold in which a casting may be made.
Synonym: wax form.
(05 Mar 2000)
convenience form The changes needed outside the basic outline form to enable proper instrumentation for the cavity preparation and insertion of a dental restoration.
(05 Mar 2000)
myocardial infarction in dumbbell form Infarction involving the septum along with both inferior and anterior walls to make an H-or dumbbell-shaped configuration.
Synonym: Roesler-Bressler infarct.
(05 Mar 2000)
posterior tooth form The distinguishing contours of the occlusal surface of the various posterior teeth.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • form master
    ÇÐ±Þ ´ãÀÓ ±³»ç
  • form sheet
    (°æ¸¶ÀÇ) ¿¹»óÁö;(Èĺ¸ÀÚ,°æ±âÀÚ¿¡ °üÇÑ) »ó¼¼ÇÑ ±â·Ï
  • form word
    =FUNCTON WORD
  • free form
    ÀÚÀ¯Çü½Ä
  • inner speech form
    ³»ºÎ ¾ð¾î Çü½Ä
  • progressive form
    ÁøÇàÇü
  • racing form
    °æ¸¶ ½Å¹®
  • re-form
    ´Ù½Ã(°íÃÄ)¸¸µé´Ù;ÀçÆí¼º(°³Æí)ÇÏ´Ù;´Ù½Ã ÇüÅ·ΠÀÌ·ç´Ù
  • sonata form
    ¼Ò³ªÅ¸ Çü½Ä
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á